TY - JOUR
T1 - Amyotrophic lateral sclerosis
T2 - Pathogenesis, differential diagnoses, and potential interventions
AU - Patel, Sarju A.
AU - Maragakis, Nicholas J.
PY - 2002/1/1
Y1 - 2002/1/1
N2 - Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative motor neuron disease. The etiology is likely multifactorial, involving both genetic and environmental factors. Method: Literature review. Findings: Motor neuron death is believed to arise from mutations in superoxide dismutase 1. Abnormal neurofilament metabolism, glutamate transporter dysfunction, and altered responses to growth factors may play a role. These discoveries have highlighted possible interventions, several of which have subsequently undergone human clinical trials. These include studies of antioxidants, antiglutamatergic agents, cyclooxygenase inhibitors, and various growth factors. Conclusion: Findings are inconclusive, and further investigations are underway. At present, nonpharmacologic interventions such as nutritional support; physical, speech, and occupational therapy; and respiratory management offer the best means of improving quality of life for patients with ALS.
AB - Background: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative motor neuron disease. The etiology is likely multifactorial, involving both genetic and environmental factors. Method: Literature review. Findings: Motor neuron death is believed to arise from mutations in superoxide dismutase 1. Abnormal neurofilament metabolism, glutamate transporter dysfunction, and altered responses to growth factors may play a role. These discoveries have highlighted possible interventions, several of which have subsequently undergone human clinical trials. These include studies of antioxidants, antiglutamatergic agents, cyclooxygenase inhibitors, and various growth factors. Conclusion: Findings are inconclusive, and further investigations are underway. At present, nonpharmacologic interventions such as nutritional support; physical, speech, and occupational therapy; and respiratory management offer the best means of improving quality of life for patients with ALS.
KW - Amyotrophic lateral sclerosis
KW - Clinical trials
KW - Glutamate
KW - Motor neuron diseases
KW - Superoxide dismutase
UR - http://www.scopus.com/inward/record.url?scp=0036887265&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036887265&partnerID=8YFLogxK
U2 - 10.1080/10790268.2002.11753626
DO - 10.1080/10790268.2002.11753626
M3 - Review article
C2 - 12482167
AN - SCOPUS:0036887265
SN - 1079-0268
VL - 25
SP - 262
EP - 273
JO - Journal of Spinal Cord Medicine
JF - Journal of Spinal Cord Medicine
IS - 4
ER -